Partnering with Top Researchers Globally
Atomwise, a pioneering company in AI-driven drug discovery, has collaborated with leading academic, government, and non-profit research institutes worldwide to tackle complex chemistry challenges and validate the effectiveness of their cutting-edge technology. Through the AIMS program, Atomwise has established over 250 partnerships with top universities and research institutions, resulting in the development of joint intellectual property in innovative compounds. These collaborative efforts have addressed more than 600 unique targets across various disease areas, demonstrating the diverse applications and impact of Atomwise's technology in advancing scientific research.